592 related articles for article (PubMed ID: 12738748)
21. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells.
Isoai A; Giga-Hama Y; Shinkai K; Mukai M; Akedo H; Kumagai H
Cancer Res; 1992 Mar; 52(6):1422-6. PubMed ID: 1311631
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.
Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M
Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825
[TBL] [Abstract][Full Text] [Related]
23. Free exchange across cells, and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A (imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate) on KB tumor cells.
Frausin F; Scarcia V; Cocchietto M; Furlani A; Serli B; Alessio E; Sava G
J Pharmacol Exp Ther; 2005 Apr; 313(1):227-33. PubMed ID: 15579494
[TBL] [Abstract][Full Text] [Related]
24. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
Sava G; Capozzi I; Clerici K; Gagliardi G; Alessio E; Mestroni G
Clin Exp Metastasis; 1998 May; 16(4):371-9. PubMed ID: 9626816
[TBL] [Abstract][Full Text] [Related]
26. Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity.
Novohradský V; Bergamo A; Cocchietto M; Zajac J; Brabec V; Mestroni G; Sava G
Dalton Trans; 2015 Jan; 44(4):1905-13. PubMed ID: 25489765
[TBL] [Abstract][Full Text] [Related]
27. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
[TBL] [Abstract][Full Text] [Related]
28. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance.
Kimura Y; Taniguchi M; Baba K
Anticancer Res; 2002; 22(6A):3309-18. PubMed ID: 12530080
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration.
Cocchietto M; Zorzet S; Sorc A; Sava G
Invest New Drugs; 2003 Feb; 21(1):55-62. PubMed ID: 12795530
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Naglich JG; Jure-Kunkel M; Gupta E; Fargnoli J; Henderson AJ; Lewin AC; Talbott R; Baxter A; Bird J; Savopoulos R; Wills R; Kramer RA; Trail PA
Cancer Res; 2001 Dec; 61(23):8480-5. PubMed ID: 11731431
[TBL] [Abstract][Full Text] [Related]
32. Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells.
Frausin F; Cocchietto M; Bergamo A; Scarcia V; Furlani A; Sava G
Cancer Chemother Pharmacol; 2002 Nov; 50(5):405-11. PubMed ID: 12439599
[TBL] [Abstract][Full Text] [Related]
33. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
Nakajima M; Welch DR; Belloni PN; Nicolson GL
Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
35. Tumor growth and metastasis increases the serum concentration of basement membrane proteins.
Dickneite G; Sedlacek HH; Timpl R; Seiler FR
Behring Inst Mitt; 1985 Dec; (78):159-66. PubMed ID: 3914282
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines.
Pluim D; van Waardenburg RC; Beijnen JH; Schellens JH
Cancer Chemother Pharmacol; 2004 Jul; 54(1):71-8. PubMed ID: 15034754
[TBL] [Abstract][Full Text] [Related]
37. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S
Amino Acids; 2008 Feb; 34(2):251-6. PubMed ID: 17356804
[TBL] [Abstract][Full Text] [Related]
38. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
[TBL] [Abstract][Full Text] [Related]
39. A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.
Rademaker-Lakhai JM; van den Bongard D; Pluim D; Beijnen JH; Schellens JH
Clin Cancer Res; 2004 Jun; 10(11):3717-27. PubMed ID: 15173078
[TBL] [Abstract][Full Text] [Related]
40. A new in vitro assay for quantitating tumor cell invasion.
Repesh LA
Invasion Metastasis; 1989; 9(3):192-208. PubMed ID: 2722434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
